export const alerts = [
  {
    id: 1,
    company: "Shield AI",
    company_name: "Shield AI",
    type: "opportunity",
    category: "regulatory",
    title: "DoD Increases Autonomous Systems Budget by 40%",
    description: "The Department of Defense announced a 40% budget increase for autonomous systems programs in the FY2027 budget proposal, with specific funding for the Collaborative Combat Aircraft (CCA) program Shield AI is competing in. This represents one of the largest single-year increases in autonomous defense spending. The CCA program alone is allocated $5.8B over the next 5 years, with Shield AI's Hivemind AI pilot platform among the leading contenders for the primary autonomy stack.",
    impact: "Massive tailwind — directly increases TAM for Shield AI's Hivemind AI pilot platform. The CCA program funding could accelerate Shield AI's revenue 2-3x over the next 18 months, potentially moving them from $200M to $500M+ ARR. This also validates the broader autonomous defense thesis, making Shield AI a more attractive acquisition target for prime contractors like Boeing or Lockheed Martin.",
    action_items: [
      "Schedule call with Shield AI CEO to discuss CCA program positioning and competitive landscape",
      "Review our portfolio allocation — consider increasing position given expanded TAM",
      "Monitor prime contractor M&A activity; Shield AI's valuation could shift significantly"
    ],
    date: "2026-01-25",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 2,
    company: "Mercury",
    company_name: "Mercury",
    type: "threat",
    category: "regulatory",
    title: "OCC Announces New BaaS Oversight Framework",
    description: "The Office of the Comptroller of the Currency proposed new oversight requirements for banking-as-a-service partnerships, potentially requiring fintechs like Mercury to meet additional compliance and capital requirements. The proposed rule would mandate quarterly examinations of BaaS relationships and require fintechs to maintain higher capital reserves. Industry groups estimate compliance costs could increase 30-50% for mid-stage fintechs operating through bank partnerships.",
    impact: "Could increase Mercury's compliance costs by $5-15M annually and slow new product launches by 3-6 months as they navigate additional regulatory hurdles. However, this could actually benefit Mercury long-term — they have the scale and resources to absorb these costs, while smaller neobank competitors may not survive the increased burden. Mercury should accelerate their bank charter application as a strategic hedge against further BaaS regulation.",
    action_items: [
      "Request Mercury's regulatory compliance team assessment of the proposed rule's impact on their roadmap",
      "Evaluate whether this accelerates or delays Mercury's IPO timeline",
      "Monitor competitor responses — this could be a consolidation catalyst"
    ],
    date: "2026-01-23",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 3,
    company: "Headway",
    company_name: "Headway",
    type: "opportunity",
    category: "market",
    title: "UnitedHealthcare Expands Headway Partnership Nationwide",
    description: "UnitedHealthcare expanded its Headway partnership to all 50 states, making Headway's 40,000+ therapist network available to all UHC members nationwide. This is the largest single payer partnership in mental health history, covering over 50 million UHC members. The deal includes an exclusive preferred network designation, meaning UHC will actively route members to Headway-credentialed providers first. Revenue impact is estimated at $200-400M annually at full utilization.",
    impact: "Transformative — this could double Headway's patient volume within 12 months and validates their platform at unprecedented scale. The exclusive preferred network status creates a significant competitive moat. More importantly, this serves as proof of concept for other major payer partnerships — Cigna, Aetna, and Anthem are all watching closely. If Headway executes well, they could lock in 3-4 major payer deals in 2026, positioning them as the dominant mental health infrastructure company.",
    action_items: [
      "Schedule quarterly review with Headway leadership to track UHC partnership utilization metrics",
      "Begin discussions with Headway about potential follow-on investment before valuation resets",
      "Introduce Headway to our Cigna and Aetna contacts to accelerate next partnership conversations"
    ],
    date: "2026-01-22",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 4,
    company: "Chime",
    company_name: "Chime",
    type: "threat",
    category: "regulatory",
    title: "Durbin Amendment Expansion Bill Introduced in Senate",
    description: "Senator Durbin introduced legislation to expand interchange fee caps to debit cards issued by fintechs, which currently operate through partner banks exempt from the original Durbin Amendment (banks under $10B in assets). The bill has bipartisan support with 12 co-sponsors and backing from major retail industry associations. If passed, interchange rates for fintech-issued debit cards could drop from ~1.5% to ~0.5%, directly impacting Chime's primary revenue stream which accounts for approximately 70% of their total revenue.",
    impact: "Significant threat to Chime's interchange-based business model — at current transaction volumes, this could reduce annual revenue by $800M-1.2B. Chime's stock (CHYM) already dropped 8% on the news. However, the legislative timeline is likely 12-18 months, giving Chime time to diversify revenue streams through their credit products and Chime Enterprise B2B offering. The broader neobank sector would be affected, but Chime's scale gives them the best chance of adapting.",
    action_items: [
      "Review Chime's revenue diversification roadmap — assess how quickly non-interchange revenue can scale",
      "Monitor legislative progress through our DC policy contacts; assess probability of passage",
      "Stress-test our portfolio exposure to interchange-dependent business models"
    ],
    date: "2026-01-21",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 5,
    company: "Plaid",
    company_name: "Plaid",
    type: "opportunity",
    category: "market",
    title: "CFPB 1033 Implementation Deadline Approaching — Banks Scrambling",
    description: "Major banks are rushing to comply with CFPB's open banking 1033 rule, with the first compliance deadline approaching in Q3 2026. JPMorgan, Wells Fargo, and Bank of America have all announced integration partnerships in the past month, with several turning to Plaid's infrastructure rather than building proprietary API solutions. The rule requires banks to provide consumers access to their financial data through standardized APIs — exactly the infrastructure Plaid has built over the past decade. Industry analysts estimate the compliance market is worth $3-5B in initial implementation.",
    impact: "Direct revenue driver — banks signing integration contracts accelerates Plaid's institutional revenue and fundamentally shifts their business model from consumer-permissioned data to bank-mandated infrastructure. This strengthens the IPO narrative significantly, as Plaid transitions from 'controversial screen-scraper' to 'regulatory-mandated financial infrastructure.' Revenue growth could re-accelerate to 40%+ as institutional contracts (higher ACV, longer term) layer onto existing consumer revenue.",
    action_items: [
      "Request Plaid's updated IPO timeline given the 1033 tailwind — this could accelerate to late 2026",
      "Review our position sizing — Plaid may be our highest-conviction IPO candidate this cycle",
      "Assess potential secondary market opportunities to increase position before IPO pricing"
    ],
    date: "2026-01-20",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 6,
    company: "Hummingbird",
    company_name: "Hummingbird",
    type: "opportunity",
    category: "market",
    title: "Second Top-20 Bank Signs Multi-Year Contract",
    description: "Hummingbird closed its second major bank deal — a 3-year, $8M contract with a top-20 US bank for its AI-powered investigation and SAR filing platform. This follows the top-10 bank win in Q4 2025. The deal includes full platform deployment across the bank's compliance operations (2,500+ investigators) and marks the first time a major bank has committed to AI-generated suspicious activity reports as primary filings. FinCEN's recent guidance endorsing AI-assisted compliance appears to be the catalyst for faster enterprise adoption.",
    impact: "Proves enterprise sales motion is repeatable — this is the second major bank in 4 months. Combined with the FinCEN endorsement, Hummingbird is positioned for rapid enterprise expansion. The $8M contract size also validates premium pricing. At this trajectory, Hummingbird could hit $30M ARR by year-end, making them a compelling Series B candidate at $300M+ valuation. The regulatory tailwind (FinCEN endorsement + growing AML scrutiny) creates a durable demand cycle.",
    action_items: [
      "Accelerate our Series B due diligence — competitive rounds are likely given this traction",
      "Introduce Hummingbird to 3 additional banks in our LP network for pipeline development",
      "Evaluate increasing our target allocation given the accelerating enterprise traction"
    ],
    date: "2026-01-19",
    priority: "high",
    read: false,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 7,
    company: "Carbon Health",
    company_name: "Carbon Health",
    type: "threat",
    category: "competitive",
    title: "Amazon One Medical Announces Aggressive Expansion — 100 New Clinics",
    description: "Amazon's One Medical division announced plans to open 100 new clinics in 2026, many in markets where Carbon Health operates (SF Bay Area, LA, Seattle, NYC). Amazon is offering free One Medical memberships to Prime subscribers (180M+ US members) and pricing visits at $0 copay for Prime members with insurance. The expansion is backed by $2B+ in Amazon Health investment and leverages Amazon's logistics infrastructure for same-day lab results and pharmacy delivery. This represents Amazon's most aggressive push into primary care.",
    impact: "Significant competitive pressure in overlapping markets. Amazon's free membership model could draw away Carbon Health's price-sensitive patients, particularly in urban markets where both operate. Carbon Health's advantages are value-based care contracts with employers and insurers, hybrid virtual/in-person model, and specialized care pathways — none of which Amazon has replicated yet. However, Amazon's distribution power (180M Prime members) and willingness to operate at a loss make them a formidable competitor. Carbon needs to accelerate insurance-based model advantages and deepen employer relationships to differentiate.",
    action_items: [
      "Schedule strategy session with Carbon Health CEO to discuss competitive response plan",
      "Analyze patient overlap — what % of Carbon Health patients are Prime members in expansion markets?",
      "Evaluate Carbon Health's unit economics in markets where Amazon One Medical already operates"
    ],
    date: "2026-01-18",
    priority: "high",
    read: true,
    stage: "portfolio",
    company_stage: "portfolio"
  },
  {
    id: 8,
    company: "Gusto",
    company_name: "Gusto",
    type: "opportunity",
    category: "market",
    title: "Gusto Embedded Finance Pilot Exceeds Expectations",
    description: "Gusto's pilot program for embedded lending (small business loans offered through the payroll platform) exceeded targets by 150%, originating $50M in loans in Q4 2025. Repayment rates are 98%+, significantly above industry benchmarks for SMB lending. The program leverages Gusto's unique data advantage — they see real-time payroll, revenue, and cash flow data for 300K+ small businesses, enabling risk assessment that traditional lenders can't match. Gusto is now planning a full rollout to all customers in Q2 2026, with a target of $500M in annual originations by year-end.",
    impact: "Validates the embedded finance thesis — Gusto's payroll data creates a proprietary risk model that dramatically reduces default rates. At $500M annual originations with 98% repayment and estimated 8% net interest margin, this could add $200M+ in incremental high-margin revenue. This significantly increases ARPU (from ~$50/employee/month to potentially $80+) and strengthens the IPO narrative by demonstrating platform economics beyond pure SaaS. The lending product also increases customer stickiness as businesses become dependent on the credit facility.",
    action_items: [
      "Deep dive into Gusto's credit risk model — request detailed default analysis and customer segmentation",
      "Compare Gusto's embedded lending metrics to Square Capital and Shopify Capital benchmarks",
      "Discuss with Gusto's CFO how embedded finance impacts IPO timing and valuation expectations"
    ],
    date: "2026-01-16",
    priority: "high",
    read: true,
    stage: "portfolio",
    company_stage: "portfolio"
  }
];
